Life Science REIT (LSE:LABS) Treasury Stock : £0.00 Mil (As of Dec. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Life Science REIT Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Life Science REIT's treasury stock for the quarter that ended in Dec. 2024 was £0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Life Science REIT Treasury Stock Historical Data

The historical data trend for Life Science REIT's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Life Science REIT Treasury Stock Chart

Life Science REIT Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Treasury Stock

Life Science REIT Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Treasury Stock	Get a 7-Day Free Trial			-	-	-	-	-

Life Science REIT Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Life Science REIT Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Life Science REIT PLC (LSE:LABS) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

51 Clarendon Road, First Floor Radius House, Watford, Hertfordshire, GBR, WD17 1HP

Website

https://www.lifesciencereit.co.uk

Life Science REIT PLC is the first London-listed REIT to focus on investment in properties in the life science sector in the UK. The company will invest in may include wet and dry laboratories, offices, incubators and co-working spaces, manufacturing and testing facilities, and data centers.